Orchestra BioMed Holdings Cash Flow Statement 2019-2024 | OBIO

Fifteen years of historical annual cash flow statements for Orchestra BioMed Holdings (OBIO).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-49.12$-33.61$-0.38$-0.17$0.00
$0.40$0.39$0$0$0
$5.90$4.39$-0.02$-0.01$0
$6.30$4.77$-0.02$-0.01$0
$0.00$0.03$0$0$0
$0.13$-0.21$0$0$0
$0$0$0$0$0
$-3.58$-3.62$0.12$-0.08$0
$-3.31$-0.45$0.12$-0.08$0
$-46.13$-29.29$-0.27$-0.26$0
$-0.08$-0.59$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$10.77$-63.53$0$0$0
$0$0$0$0$0
$10.77$-63.53$0$0$0
$0$0$0$-160.00$0
$10.69$-64.12$0.00$-160.00$0
$-10.85$3.55$0$0$0
$0$0$0$0$0
$-10.85$3.55$0$0$0
$0.25$110$0$6.03$0
$0.25$110$0$6.03$0
$0$0$0$0$0
$56.81$-10.32$0$156$0
$46.22$103$0.00$162$0
$10.78$9.85$-0.27$2.03$0
$7.63$3.41$0$0$0
$0$0$0$0$0